Authors
Loading...
A novel protocol enables the N-alkylation of sulfoximines, enhancing drug-like properties in lead compounds.
Großkopf et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: